Stock Scorer

OBSERVE MEDICAL ASA (OBSRV.OL)

These figures are from 2023-12-31. Nothing newer has been filed in the 33 months since.

OBSERVE MEDICAL ASA reported revenue of 27.9M NOK for the year ending 31 December 2023, up 43.1% from 19.5M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in NOK. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in NOK.
FigurePeriodAmountYear on year
Revenue 2023 · ending 31 December 2023 27.9M +43.1%
Gross Profit 2023 · ending 31 December 2023 9.3M +79.4%
Operating Income 2023 · ending 31 December 2023 -51.3M
Net Income 2023 · ending 31 December 2023 -60.4M
Operating Cash Flow 2023 · ending 31 December 2023 -24.5M

Revenue and profit by financial year

As filed, in NOK. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20232023-12-31 27.9M-51.3M-60.4M
20222022-12-31 19.5M-59.1M-50.8M
20212021-12-31 24M-36.5M-26.3M
20202020-12-31 3M-28.1M-36.9M

Every period

Revenue Annual

PeriodEndingRevenue
FY232023-12-3127.9M
FY222022-12-3119.5M
FY212021-12-3124M
FY202020-12-313M

Gross Profit Annual

PeriodEndingGross Profit
FY232023-12-319.3M
FY222022-12-315.2M
FY212021-12-319.5M
FY202020-12-31986K

Operating Income Annual

PeriodEndingOperating Income
FY232023-12-31-51.3M
FY222022-12-31-59.1M
FY212021-12-31-36.5M
FY202020-12-31-28.1M

Net Income Annual

PeriodEndingNet Income
FY232023-12-31-60.4M
FY222022-12-31-50.8M
FY212021-12-31-26.3M
FY202020-12-31-36.9M

Operating Cash Flow Annual

PeriodEndingOperating Cash Flow
FY232023-12-31-24.5M
FY222022-12-31-51.3M
FY212021-12-31-22.1M
FY202020-12-31-21.6M